Gene recombination human interferon alpha 2b liposome and injection, suppository, eye drop, sparying preparation and ointment thereof

A technology of gene recombination and interferon α, applied in liposome delivery, suppository delivery, aerosol delivery, etc., can solve the problems of enzyme system damage and inactivation, poor stability, short biological half-life, etc., and achieve biological activity unchanged , improved stability, and strong sustained-release effect

Inactive Publication Date: 2005-12-07
TIANJIN CITY HENGTIAN BIOLOGICAL TECH
View PDF0 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The results of clinical application show that recombinant human interferon α is used for the treatment of hepatitis B, but it has the disadvantages of low clinical effective rate, large toxic and side effects, and many times of administration
[0003] At present, there are mainly the following problems in the treatment of interferon: 1) After entering the body fluid, it is easily destroyed and inactivated by the enzyme system in the body, and the biological half-life in the body is short
2) Interferon is absorbed and distributed throughout the body, and the amount of interferon reaching the lesion is very limited
Therefore, after intramuscular injection of interferon, the amount of effective drug that reaches the liver

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

example 1

[0019] Example 1, recombinant human interferon α2b liposome

[0020] prescription:

[0021] Soybean lecithin for injection 125mg, cholesterol 15.25mg, fat oil 75μg, colloidal silicon 40μg, recombinant human interferon α2b 6×10 6 IU.

[0022] Preparation method: Weigh soybean lecithin and cholesterol for injection, put them in a round bottom flask, add chloroform:ethanol as 1:1 mixed solvent appropriate amount, dissolve, evaporate under reduced pressure on a rotary evaporator to remove the solvent, and continue vacuum drying for 12 hours , form a lipid film on the wall of the flask, add fatty oil and colloidal silica gel (containing medicine), hydrate in a water bath at 40°C for 1 hour, stir magnetically for 1 hour, cool to room temperature, and obtain. Under sterile conditions, filter through a microporous membrane of 0.45 μg, separate the free drug by high-speed centrifugation (250000r / m, 30min), take the clear liquid and use the CPE method to measure the biological activity

example 2

[0023] Example 2, recombinant human interferon α2b liposome

[0024] prescription:

[0025] Soybean lecithin for injection 150mg, cholesterol 50mg, fatty oil 200μg, colloidal silicon 200μg, recombinant human interferon 8×10 7 IU.

[0026] The method of making is the same as above.

example 3

[0027] Example 3, Gene Recombinant Human Interferon α2b Liposome

[0028] prescription:

[0029] Soybean lecithin for injection 45mg, cholesterol 5mg, fatty oil 10μg, colloidal silicon 10μg, recombinant human interferon 2×10 6 IU.

[0030] The method of making is the same as above.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

Disclosed is a gene recombinant human interferon alpha 2b liposome comprising the following constituents, bean phospholipin 50-150mg, cholesterin 5-50mg, fatty oil 10-200ug, colloid silicon 10-200ug and interferon. By adding the conventional auxiliary materials into the gene recombinant human interferon alpha 2b liposome, the dosage forms of injection, suppository, eye drops, spray and electuary can be obtained.

Description

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Owner TIANJIN CITY HENGTIAN BIOLOGICAL TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products